CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Centessa Pharmaceuticals CEO Touts ORX750 as Best-in-Class as Registration Studies Nearing Start [Yahoo! Finance]
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference [Yahoo! Finance]
Forget Centessa Pharmaceuticals: This Rare-Disease Specialist Has a Superior Portfolio and Pipeline [Yahoo! Finance]
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
Form 4 Centessa Pharmaceuticals For: Mar 26 Filed by: Anderson Karen M.
Form 4 Centessa Pharmaceuticals For: Mar 26 Filed by: Weinhoff Gregory M
Form 144 Centessa Pharmaceuticals Filed by: Weinhoff Gregory M
Form 144 Centessa Pharmaceuticals Filed by: Anderson Karen M.
Form 4 Centessa Pharmaceuticals For: Mar 16 Filed by: Anderson Karen M.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.